Categories
Latest Blog Posts
- New Biological Mechanism Boosts Myelin Production in the Brain
- 4 Vitamin B12 Deficiency Symptoms You Need to Know
- Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
- Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
- UIC Study: Remote Pilates Program for People Living with MS
- Exercise and Cognition in Multiple Sclerosis in 2025: Forward Momentum or Going Nowhere Fast?
- Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed
- Trigeminal neuralgia and MS
- What Is an MS Zinger and How Can You Manage It?
- What to know about itching and MS
- Two compounds with potential for myelin repair in MS identified
- Losing my sense of safety after an MS relapse
- 7 Ways to Navigate Your Health Insurance With MS
- Big Changes Are Coming for 2026 Medicare Plans. What You Need to Know.
- Exercise in MS eases fatigue, improves muscular fitness: Analysis
- Could Ultra-Processed Foods Make Your MS Worse?
- VIRTUAL Physical Therapy – (each month) – “MOVING WITH MS” –
- The New MS Diagnostic Criteria: What You Need To Know
- Octave wins grant to develop blood test for measuring MS progression
- With new data, Quantum moves closer to launching trial of Lucid-MS – a potential treatment for targeting demyelination
